Showing results (81-90 of 103) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapyW S Dalton, T M Grogan, P S Meltzer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trialB W Dana, S Dahlberg, T P Miller, et al.Blood|April 1, 1988
Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67T M Grogan, S M Lippman, C M Spier, et al.Journal of Dairy Science|September 1, 1992
Sodium bicarbonate or multielement buffer via diet or rumen: effects on performance and acid-base status of lactating cowsW B Tucker, M Aslam, M Lema, et al.American Journal of Clinical Pathology|March 1, 1985
Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypesT M Grogan, K Fielder, C Rangel, et al.The New England Journal of Medicine|July 2, 1998
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphomaT P Miller, S Dahlberg, J R Cassady, et al.The New England Journal of Medicine|April 8, 1993
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomaR I Fisher, E R Gaynor, S Dahlberg, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma StudyR I Fisher, E R Gaynor, S Dahlberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group StudyT P Miller, T T Chen, C A Coltman, et al.Blood|March 15, 1994
Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trialT P Miller, T M Grogan, S Dahlberg, et al.Pageof 11